Phase II Trial of Docetaxel, Bevacizumab, Lenalidomide, and Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer
Madan, Ravi A., Karzai, Fatima H., Ning, Yang-Min, Adesunloye, Bamidele A., Huang, Xuan, Harold, Nancy, Couvillon, Anna, Chun, Guinevere, Cordes, Lisa, Sissung, Tristan, Beedie, Shaunna L., Dawson, NaМова:
english
Журнал:
BJU International
DOI:
10.1111/bju.13412
Date:
January, 2016
Файл:
PDF, 246 KB
english, 2016
File converter
Більше результатів пошуку
More benefits 
